Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 670.5 JPY 0.39% Market Closed
Market Cap: 606.7B JPY
Have any thoughts about
Santen Pharmaceutical Co Ltd?
Write Note

Santen Pharmaceutical Co Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Santen Pharmaceutical Co Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Santen Pharmaceutical Co Ltd
TSE:4536
Long-Term Investments
ÂĄ24.6B
CAGR 3-Years
-14%
CAGR 5-Years
-2%
CAGR 10-Years
-1%
Takeda Pharmaceutical Co Ltd
TSE:4502
Long-Term Investments
ÂĄ277.3B
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
1%
Daiichi Sankyo Co Ltd
TSE:4568
Long-Term Investments
ÂĄ154.5B
CAGR 3-Years
4%
CAGR 5-Years
8%
CAGR 10-Years
0%
Otsuka Holdings Co Ltd
TSE:4578
Long-Term Investments
ÂĄ503.5B
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
5%
Chugai Pharmaceutical Co Ltd
TSE:4519
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Long-Term Investments
ÂĄ132.9B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
4%
No Stocks Found

Santen Pharmaceutical Co Ltd
Glance View

Market Cap
594.1B JPY
Industry
Pharmaceuticals

Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. The company is headquartered in Osaka, Osaka-Fu and currently employs 4,229 full-time employees. The firm has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The firm engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The firm operates in Japan, Europe, Asia, North America markets.

Intrinsic Value
2 142.23 JPY
Undervaluation 22%
Intrinsic Value
Price

See Also

What is Santen Pharmaceutical Co Ltd's Long-Term Investments?
Long-Term Investments
24.6B JPY

Based on the financial report for Jun 30, 2024, Santen Pharmaceutical Co Ltd's Long-Term Investments amounts to 24.6B JPY.

What is Santen Pharmaceutical Co Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
-1%

Over the last year, the Long-Term Investments growth was -38%. The average annual Long-Term Investments growth rates for Santen Pharmaceutical Co Ltd have been -14% over the past three years , -2% over the past five years , and -1% over the past ten years .

Back to Top